39
Participants
Start Date
November 11, 2024
Primary Completion Date
December 5, 2029
Study Completion Date
December 11, 2029
Nipocalimab
Nipocalimab will be administered intravenously.
Placebo
Placebo will be administered intravenously.
RECRUITING
Univerzitetni klinicni center Ljubljana, Ljubljana
RECRUITING
Centre Hospitalier Universitaire Vaudois CHUV, Lausanne
RECRUITING
Semmelweis Egyetem, Budapest
RECRUITING
Universitair Ziekenhuis Leuven, Leuven
RECRUITING
Haukeland University Hospital, Bergen
RECRUITING
St. Olavs Hospital, Trondheim
RECRUITING
Universitetssykehuset Nord-Norge HF, Tromsø
RECRUITING
Hosp. Virgen Del Rocio, Seville
RECRUITING
CHRU Lille, Lille
RECRUITING
Hopital trousseau- APHP, Paris
RECRUITING
Sheba Medical Center, Ramat Gan
RECRUITING
Instituto de Medicina Integral Professor Fernando Figueira, Recife
RECRUITING
Instituto D Or de Pesquisa e Ensino IDOR, Rio de Janeiro
RECRUITING
Hospital Das Clinicas Da Faculdade De Medicina Da USP, São Paulo
RECRUITING
Fondazione Policlinico Universitario A Gemelli IRCCS, Rome
RECRUITING
Oslo University Hospital HF Ulleval sykehus, Oslo
RECRUITING
Univerzitna nemocnica L. Pasteura Kosice, Košice
RECRUITING
Univerzitná nemocnica Martin, Martin
RECRUITING
Fakultna nemocnica s poliklinikou Nove Zamky, Nové Zámky
RECRUITING
Karolinska Universitetssjukhuset Huddinge, Stockholm
Janssen Research & Development, LLC
INDUSTRY